Life Sciences & Biomedical Research
Upcoming Events by Topic
May 28 - 29, 2013 | Spain
Explore Plasmodium vivax biology and genomics; drug resistance and discovery; and recent clinical trial and in-field efforts in P. vivax malaria prevention, treatment, control, and elimination.
Thursday, May 30, 2013 | 9:00 AM - 5:00 PM
Review progress on key aspects of the Plasmodium vivax research agenda as they pertain to malaria treatment, control, and elimination through a series of free, interdisciplinary workshops.
Monday, June 3, 2013 | 1:00 PM - 4:00 PM
Organizers: John Petrini (Memorial Sloan-Kettering Cancer Center), Rodney Rothstein (Columbia University Medical Center), Lorraine Symington (Columbia University Medical Center)
Keynote Speaker: Stephen West (London Research Institute, Cancer Research UK)
The Genome Integrity Discussion Group provides a forum for interactions between basic and clinical research groups working on chromosome biology and function, and at the interface between chromosome integrity and onset and progression of malignancy.
Wednesday, June 5, 2013 | 12:00 PM - 4:00 PM
Keynote Speaker: Alanna Schepartz (Yale University)
Speakers: Han Guo (Luo lab, Memorial Sloan–Kettering Cancer Center), Rudy Jacquet (Montclare lab, NYU-Poly), Neel Shah (Muir lab, Princeton University), Monika Raj (Arora lab, NYU), Wenjiao Song (Jaffrey lab, Weill Medical College, Cornell University), and Carola Wilczek (Shechter lab, Albert Einstein College of Medicine)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Professor Alanna Schepartz of Yale University and a poster session.
Thursday, June 6, 2013 | 8:30 AM - 6:30 PM
Organizers: Sharon Akabas (Columbia University), Gerald Friedman (The Mount Sinai Hospital), Martin Kohlmeier (University of North Carolina), Charlotte Pratt (National Institute of Health), Gwen Twillman (American Society for Nutrition), Mandana Arabi (The Sackler Institute for Nutrition Science), Brooke Grindlinger (The New York Academy of Sciences)
This conference aims to revisit the current nutrition curricula for health professionals and to explore how trainings can better provide the skills necessary for implementing the array of preventative and therapeutic nutrition interventions available. Presented as part of the Translational Medicine Initiative.
June 11 - 13, 2013
Organizers: Mark E. Davis (California Institute of Technology, Pasadena), Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School), Brooke Grindlinger (The New York Academy of Sciences), Melanie Brickman Stynes (The New York Academy of Sciences), Roger Kornberg (Stanford University School of Medicine), Robert S. Langer (Massachusetts Institute of Technology), Konstantin Severinov (Rutgers the State University of New Jersey)
Throughout the past decade nanoparticles, and specifically nanoparticle drug delivery systems, have emerged at the forefront of cancer therapies. This conference will discuss: nanodiagnostics for cancer biomarkers and imaging, toxicity and safety; nanovaccines and nanoimmunotherapeutics; targeted delivery in tumors; and nanoparticle-based gene therapy.
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM
In-house event is SOLD OUT! Register for the live webinar.
Speakers: Martin J. Blaser (New York University School of Medicine), Sir Harry Burns (Scottish Government, Scotland), Patrice D. Cani (Université Catholique de Louvain, Belgium), Fred H. Degnan (King & Spalding LLP), Joël Doré (Institut National de la Recherche Agronomique, France), Jane A. Foster (McMaster University, Canada), Gary Frost (Imperial College London, United Kingdom), Patricia L. Hibberd (Harvard Medical School / Massachusetts General Hospital for Children), John Hutton (University of York, United Kingdom), Todd Klaenhammer (North Carolina State University), David A. Mills (University of California, Davis), Max Nieuwdorp (University of Amsterdam, The Netherlands), Bruno Pot (Institut Pasteur de Lille, France), Rowena Pullan (Pfizer Consumer Healthcare), Helen E. Raybould (University of California, Davis), Gregor Reid (Western University / Lawson Health Research Institute, Canada), David A. Relman (Stanford University School of Medicine), Andrew Serazin (Matatu LLC)
Explore research and policy strategies to translate scientific knowledge on the convergence of the microbiome, prebiotics, probiotics, and host physiology into nutritional and therapeutic applications for inflammation, obesity, diabetes, gastrointestinal disease, and malnutrition.
June 19 - 20, 2013
Conference Planning Committee: Claudio Carini (Pfizer Inc.), Teresa Compton (Biogen Idec (Conference Chair)), Marion Kasaian (Pfizer Inc.), Theodora Salcedo (Bristol-Myers Squibb Company), Anne Vogt (F. Hoffmann-La Roche Ltd)
Scientific Advisory Board: Leonard Calabrese (Cleveland Clinic), Paola Cinque (Hospital San Raffaele), David Clifford (Washington University School of Medicine), Robert Garcea (University of Colorado at Boulder), Eugene Major (National Institute of Neurological Disorders and Stroke), Kenneth Tyler (University of Colorado Anschutz Medical Campus), Thomas Weber (University of Hamburg)
New basic science and clinical findings relevant to the pathogenesis, mitigation, cure, and risk stratification of Progressive Multifocal Leukoencephalopathy will support a discussion of current challenges and future directions for PML treatment.
Monday, June 24, 2013 | 10:30 AM - 3:00 PM
Speakers: Yasmine Belkaid (National Institute of Allergy and Infectious Diseases, NIH), Dan R. Littman (New York University School of Medicine), Alexander Rudensky (Memorial Sloan-Kettering Cancer Center)
The Ross Prize, established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine, is awarded to an investigator producing innovative, paradigm-shifting research worthy of significant attention in molecular medicine.
Wednesday, September 18, 2013 | 5:00 PM - 6:45 PM
Moderator: Orla M. Smith (Science Translational Medicine)
Panelists: Amanda Boxtel (Ekso Bionics), Grégoire Courtine (Swiss Federal Institute of Technology, EPFL), Nathan Harding (Ekso Bionics)
Join us for a discussion of cutting-edge technologies that may revolutionize spinal cord injury rehabilitation and treatment. Included in the discussion is a live demonstration of a wearable robot (or exoskeleton) that enables people with lower-extremity paralysis or weakness to stand and walk. We will present perspectives from an innovator, a researcher, and a patient, who will share their insights on how these new technologies benefit the public now and in the future to come.